Brief: Gossamer Bio To Provide Updated Seralutinib TORREY Open-Label Extension Data At The American Thoracic Society 2024 International Conference
14/05/2024 21:04
May 14 (Reuters) - Gossamer Bio Inc GOSS.O :
* GOSSAMER BIO TO PROVIDE UPDATED SERALUTINIB TORREY
OPEN-LABEL
EXTENSION DATA AT THE AMERICAN THORACIC SOCIETY 2024
INTERNATIONAL CONFERENCE
Source text for Eikon: ID:nBw9gN13Ta
Further company coverage: GOSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gossamer Bio
See all newsBrief: Gossamer Bio Submits New Drug Application To US FDA For Seralutinib For The Treatment Of Pulmonary Arterial Hypertension
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Gossamer Bio - Board Approves Amendment And Restatement Of Bylaws Effective Sept 3, 2026 - SEC Filing